You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »
 

Anti-Tafazzin / TAZ antibody (ab40004)

CodeSizePriceAbpointsAvailability
    
 
  • -
  •   
  •   
  •   
  •  
  •   
  •   
Updating...

Overview

Product name

Anti-Tafazzin / TAZ antibody
See all Tafazzin / TAZ products (4) ...

Description

Goat polyclonal to Tafazzin / TAZ

Specificity

This antibody is expected to recognise isoforms 1 to 4. (NP_000107.1; NP_851828.1; NP_851829.1; NP_851830.1, respectively).

Tested applications

WB, ELISAmore details

Cross reactivity

Reacts with

Human

Predicted to work with

Mouse, Rat, Dog, Chimpanzee

Immunogen

Synthetic peptide:C-HLKTQAEQLHNH (Human) from the C Terminus of the protein sequence (according to NP_000107.1; NP_851828.1; NP_851829.1; NP_851830.1.).

C-HLKTQAEQ LHNH

Positive control

Human heart lysate.

Properties

Form

Liquid

Storage instructions

Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.

Storage buffer

Preservative: 0.02% Sodium Azide
Constituents: 0.5% BSA, Tris buffered saline, pH 7.3

Concentration

Concentration information loading...

Purity

Immunogen affinity purified

Clonality

Polyclonal

Isotype

IgG

  • Western blot - Tafazzin / TAZ antibody (ab40004)Western blot - Tafazzin / TAZ antibody (ab40004) image (enlarge)

Applications

Show applications key

Our Abpromise guarantee covers the use of ab40004 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application notes

ELISA: 1/32000 - antibody limit dilution.
WB: Use at a concentration of 0.3 - 1 µg/ml. Detects a band of approximately 28 kDa (predicted molecular weight: 33 kDa).

Not yet tested in other applications.
Optimal dilutions/concentrations should be determined by the end user.

Target

Function

Some isoforms may be involved in cardiolipin (CL) metabolism.

Tissue specificity

High levels in cardiac and skeletal muscle. Up to 10 isoforms can be present in different amounts in different tissues. Most isoforms are ubiquitous. Isoforms that lack the N-terminus are found in leukocytes and fibroblasts, but not in heart and skeletal muscle. Some forms appear restricted to cardiac and skeletal muscle or to leukocytes.

Involvement in disease

Defects in TAZ are the cause of 3-methylglutaconic aciduria type 2 (MGA2) [MIM:302060]; also known as Barth syndrome. MGA2 is a severe metabolic disorder, often fatal in childhood, characterized by dilated cardiomyopathy, skeletal myopathy, short stature, neutropenia and 3-methylglutaconicaciduria.
Defects in TAZ are the cause of left ventricular non-compaction X-linked (LVNCX) [MIM:300183]. LVNC is due to an arrest of myocardial morphogenesis. The disorder is characterized by a hypertrophic left ventricular with deep trabeculations and with poor systolic function, with or without associated left ventricular dilation. In some cases, the right ventricle is also affected.

Sequence similarities

Belongs to the taffazin family.

Domain

The hydrophilic domain may serve as an exposed loop interacting with other proteins.

Cellular localization

Cytoplasm and Membrane.

Target information above from: UniProt accessionQ16635 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • TAZ protein antibody
  • Cardiomyopathy dilated 3A (X linked) antibody
  • Barth syndrome antibody
  • EFE2 antibody
  • Endocardial fibroelastosis 2 antibody
  • Protein G4.5 antibody
  • Tafazzin antibody
  • TAZ antibody
  • TAZ_HUMAN antibody
see all

Anti-Tafazzin / TAZ antibody images:

  Western blot - Tafazzin / TAZ antibody (ab40004)

Western blot - Tafazzin / TAZ antibody (ab40004)

Anti-Tafazzin / TAZ antibody (ab40004) at 0.3 µg/ml + Human Heart lysate in RIPA buffer at 35 µg

Predicted band size : 33 kDa
Observed band size : 28 kDa (why is the actual band size different from the predicted?)


Primary incubation was 1 hour. Detected by chemiluminescence.

References for Anti-Tafazzin / TAZ antibody (ab40004)

This product has been referenced in:

  • Gonzalvez Fet al. Cardiolipin provides an essential activating platform for caspase-8 on mitochondria. J Cell Biol 183:681-96 (2008). WB; Human.Read more (PubMed: 19001123) »

See 1 publication for this product

Publishing research using ab40004? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"